Unlocking Orphan Pricing In France
Flawed System For Assessing Orphans Relies Too Heavily On Comparators
Executive Summary
Heath technology assessments in the competitive orphan space, such as pulmonary arterial hypertension, could get tougher in France.
You may also be interested in...
Companies Need EU Funding To Cover ‘Enormous Expenditure’ Of Complying With Revised GMP Rules
Important updates to good manufacturing practice guidelines are likely to mean medicine shortages, warns a German pharmaceutical industry group.
IGBA Welcomes Mexican Membership
The IGBA has welcomed Mexican pharmaceutical industry association ANAFAM as an associate member.
UK Considers US -Style Payment Reporting Obligations For Drug And Device Firms
The UK pharmaceutical industry association, the ABPI, would like to see its own system strengthened to improve reporting of payments to health care professionals and organizations.